References
- Campbel DB, Adrianssens P, Hopkins YW, Gordon B, Willams JRB. Pharmacokinetics and metabolism of gliclazide: a review. Gliclazide and the Treatment of Diabetes, International Congress and Symposium Series N.29. Proceedings of International Symposium, London, April 5–6, 1979, ET Keen. Academic Press and Royal Society of Medicine, London 1980; 71–82
- Kobayashi K, Kimura M, Sakoguchi T, Kitani Y, Hata M. Influence of blood proteins on biomedical analysis. III. Phannacokinetics and protein binding of gliclazide. J Pharmacobio-Dynamics 1981; 4: 436–442
- Oida T, Yoshida K, Kagemoto A, Sekine Y. The metabolism of gliclazide in man. Xenobiotica 1985; 15: 87–96
- Shiba J, Kajinuma H, Suzuki K, Hagura R, Kawai A. Serum gliclazide concentration in diabetic patients. Relationship between gliclazide and serum concentration. Diab Res Clin Practice 1986; 2: 301–306
- Kobayashi K, Kimura M, Sakoguchi T, Hase A, Matsuoka A, Kaneko S. Pharmacokinetios of gliclazide in healthy and diabetic subjects. J Pharm Sci 1984; 73: 1684–1687
- Forette B, Rolland A, Hopkins Y, Gordon B, Campbell DB. Gliclazide phannacokinetios in the elderly. 11th Congress of the International Diabetes Federation Abstracts. Excepta Medica, Amsterdam 1982
- Archambeaud-Monveroux F, Novaille Y, Nadallon S, Treves R, Merle L. Interaction between gliclazide and cimetidine. Eur J Clin Pharmacol 1987; 91: 631
- Couturier E, Roman A, Jahjah L, Sener A, Malaisse J. Plasma gliclazide measurement 5 days after ingestion of the hypoglycaemic sulfonylurea in an attempted suicide. Diabetes Research 1966; 31: 41–44
- GIN H at Coll. Hyponatrermie induite par le sulfamides Hypoglycemisants: etude dsez 70 patients. Ann Mea' Int 1966; 139: 455